TILRAY BRANDS INC (TLRY.CA) Fundamental Analysis & Valuation

TSX:TLRY • US88688T2096

Current stock price

9.58 CAD
+0.07 (+0.74%)
Last:

This TLRY.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TLRY.CA Profitability Analysis

1.1 Basic Checks

  • TLRY had negative earnings in the past year.
  • In the past year TLRY has reported a negative cash flow from operations.
  • TLRY had negative earnings in each of the past 5 years.
  • TLRY had negative operating cash flow in 4 of the past 5 years.
TLRY.CA Yearly Net Income VS EBIT VS OCF VS FCFTLRY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B -2B

1.2 Ratios

  • The Return On Assets of TLRY (-64.81%) is worse than 84.38% of its industry peers.
  • Looking at the Return On Equity, with a value of -86.34%, TLRY is doing worse than 71.88% of the companies in the same industry.
Industry RankSector Rank
ROA -64.81%
ROE -86.34%
ROIC N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
TLRY.CA Yearly ROA, ROE, ROICTLRY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

  • TLRY's Gross Margin of 27.68% is in line compared to the rest of the industry. TLRY outperforms 46.88% of its industry peers.
  • In the last couple of years the Gross Margin of TLRY has grown nicely.
  • The Profit Margin and Operating Margin are not available for TLRY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
TLRY.CA Yearly Profit, Operating, Gross MarginsTLRY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. TLRY.CA Health Analysis

2.1 Basic Checks

  • TLRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TLRY has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TLRY has more shares outstanding
  • TLRY has a worse debt/assets ratio than last year.
TLRY.CA Yearly Shares OutstandingTLRY.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TLRY.CA Yearly Total Debt VS Total AssetsTLRY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of -1.78, we must say that TLRY is in the distress zone and has some risk of bankruptcy.
  • TLRY's Altman-Z score of -1.78 is on the low side compared to the rest of the industry. TLRY is outperformed by 65.63% of its industry peers.
  • A Debt/Equity ratio of 0.18 indicates that TLRY is not too dependend on debt financing.
  • The Debt to Equity ratio of TLRY (0.18) is better than 65.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -1.78
ROIC/WACCN/A
WACC8.08%
TLRY.CA Yearly LT Debt VS Equity VS FCFTLRY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.79 indicates that TLRY has no problem at all paying its short term obligations.
  • The Current ratio of TLRY (2.79) is better than 71.88% of its industry peers.
  • TLRY has a Quick Ratio of 1.66. This is a normal value and indicates that TLRY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of TLRY (1.66) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 1.66
TLRY.CA Yearly Current Assets VS Current LiabilitesTLRY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TLRY.CA Growth Analysis

3.1 Past

  • TLRY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -394.57%.
  • TLRY shows a small growth in Revenue. In the last year, the Revenue has grown by 3.82%.
  • The Revenue has been growing by 37.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-394.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)3.82%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%11.28%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.42% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.15% on average over the next years.
EPS Next Y96%
EPS Next 2Y40.7%
EPS Next 3Y25.72%
EPS Next 5Y15.42%
Revenue Next Year4.58%
Revenue Next 2Y10.6%
Revenue Next 3Y10.02%
Revenue Next 5Y4.15%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TLRY.CA Yearly Revenue VS EstimatesTLRY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
TLRY.CA Yearly EPS VS EstimatesTLRY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. TLRY.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • TLRY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year TLRY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLRY.CA Price Earnings VS Forward Price EarningsTLRY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • TLRY's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.36
TLRY.CA Per share dataTLRY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TLRY's earnings are expected to grow with 25.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.7%
EPS Next 3Y25.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TLRY.CA Dividend Analysis

5.1 Amount

  • TLRY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TLRY.CA Fundamentals: All Metrics, Ratios and Statistics

TILRAY BRANDS INC

TSX:TLRY (4/15/2026, 7:00:00 PM)

9.58

+0.07 (+0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-01
Earnings (Next)07-27
Inst Owners10.42%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap1.12B
Revenue(TTM)858.27M
Net Income(TTM)-1.34B
Analysts71.76
Price Target15.96 (66.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-84.52%
Min EPS beat(2)-100.98%
Max EPS beat(2)-68.07%
EPS beat(4)1
Avg EPS beat(4)-1358%
Min EPS beat(4)-5362.97%
Max EPS beat(4)100%
EPS beat(8)1
Avg EPS beat(8)-724.95%
EPS beat(12)2
Avg EPS beat(12)-509.78%
EPS beat(16)2
Avg EPS beat(16)-638.24%
Revenue beat(2)2
Avg Revenue beat(2)0.87%
Min Revenue beat(2)0.66%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-7.23%
Max Revenue beat(4)1.09%
Revenue beat(8)3
Avg Revenue beat(8)-4.29%
Revenue beat(12)4
Avg Revenue beat(12)-2.21%
Revenue beat(16)4
Avg Revenue beat(16)-2.83%
PT rev (1m)-8%
PT rev (3m)-32.38%
EPS NQ rev (1m)-600.6%
EPS NQ rev (3m)53.34%
EPS NY rev (1m)-16.08%
EPS NY rev (3m)-18.75%
Revenue NQ rev (1m)3.71%
Revenue NQ rev (3m)2.06%
Revenue NY rev (1m)0.8%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.94
P/FCF N/A
P/OCF N/A
P/B 0.52
P/tB 1.04
EV/EBITDA 25.36
EPS(TTM)-18.81
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS10.15
BVpS18.42
TBVpS9.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -64.81%
ROE -86.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.68%
FCFM N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 8.12
Cap/Depr 35.43%
Cap/Sales 3.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.79
Quick Ratio 1.66
Altman-Z -1.78
F-Score3
WACC8.08%
ROIC/WACCN/A
Cap/Depr(3y)21.23%
Cap/Depr(5y)65.01%
Cap/Sales(3y)3.68%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-394.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y96%
EPS Next 2Y40.7%
EPS Next 3Y25.72%
EPS Next 5Y15.42%
Revenue 1Y (TTM)3.82%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%11.28%
Revenue Next Year4.58%
Revenue Next 2Y10.6%
Revenue Next 3Y10.02%
Revenue Next 5Y4.15%
EBIT growth 1Y54.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.37%
EBIT Next 3Y29.21%
EBIT Next 5Y17.22%
FCF growth 1Y-47.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-147.74%
OCF growth 3YN/A
OCF growth 5YN/A

TILRAY BRANDS INC / TLRY.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TILRAY BRANDS INC?

ChartMill assigns a fundamental rating of 2 / 10 to TLRY.CA.


Can you provide the valuation status for TILRAY BRANDS INC?

ChartMill assigns a valuation rating of 1 / 10 to TILRAY BRANDS INC (TLRY.CA). This can be considered as Overvalued.


Can you provide the profitability details for TILRAY BRANDS INC?

TILRAY BRANDS INC (TLRY.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for TLRY stock?

The financial health rating of TILRAY BRANDS INC (TLRY.CA) is 3 / 10.